Difference in Therapeutic Response Between Basal and Nonbasal Triple-Negative Breast Cancers

François Bertucci (1) , Pascal Finetti (2) , Patrice Viens (3) , Daniel Birnbaum (1)

1 CRCM - Centre de Recherche en Cancérologie de Marseille
2 IPC - Institut Paoli-Calmettes
3 Service d'Oncologie Médicale

This study, which nicely complements a study recently published in The Oncologist, shows for the first time that triple-negative breast cancers are much more heterogeneous than basal breast cancers regarding the response to chemotherapy and the probability of response to molecularly targeted therapies.

Domaines: Cancer

François Bertucci, Pascal Finetti, Patrice Viens, Daniel Birnbaum. Difference in Therapeutic Response Between Basal and Nonbasal Triple-Negative Breast Cancers. Oncologist, 2013, 18 (9), pp.1060-1061. ⟨10.1634/theoncologist.2013-0121⟩. ⟨hal-03623765⟩